No menu items!
Wednesday, July 15, 2026

breast cancer

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

India and Australia Launch New Cyber and Technology Partnership

India and Australia have launched a new strategic partnership to deepen cooperation on cybersecurity, critical technologies and resilient supply...
- Advertisement -spot_img